Polynucleotides and PDRN are increasingly discussed in regenerative aesthetics, but the terms should not automatically be treated as interchangeable. Explore their relationship, key differences, and what aesthetic professionals should consider when evaluating products.

Choosing regenerative aesthetic products requires more than following emerging trends. Discover how professional clinics can evaluate formulations, product information, sourcing, handling requirements, and supplier reliability before purchasing.

Polynucleotides, PDRN and exosome-based formulations are increasingly discussed within regenerative aesthetics. Learn how these categories differ and what aesthetic professionals should consider when evaluating products for their clinic.

Skin boosters and regenerative aesthetics are increasingly discussed together, but they do not always describe the same product types or treatment objectives. Explore the key differences and what aesthetic clinics should consider when evaluating these growing categories.

A strong skin booster portfolio is not about stocking as many products as possible. Learn how aesthetic clinics can build a balanced professional range around treatment goals, formulation categories, patient demand, and efficient inventory planning.